Oesophageal Cancer

Trial	DECIPHER
Cancer Type	Gastrointestinal, Oesophageal Cancer, and Stomach Cancer
Hospital(s)	Belfast City Hospital
Information	Developing ctDNA guided adjuvant therapy for gastrooesophageal cancer. A single arm phase II trial of trastuzumab deruxtecan in patients with gastrooesophageal adenocarcinoma cancer who are ctDNA and HER2 positive
Trial Open	Yes

Trial	ICHOR
Cancer Type	Gastrointestinal, Oesophageal Cancer, and Stomach Cancer
Hospital(s)	Belfast City Hospital
Information	Investigation of Circulating Haematological Biomarkers in Cancer
Trial Open	Yes

Trial	IDeate- Esophageal01
Cancer Type	Oesophageal Cancer
Hospital(s)	Altnagelvin Hospital
Information	A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd) in Subjects with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
Trial Open	Yes
	Click Here to view trial summary